Vimarsana
Biggest News Aggregation in the World

Largest Series News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Largest Series. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Largest Series Today - Breaking & Trending Today

Wa'ed Ventures Leads a US $27 Million Series A Round for Rewaa, with Participation from STC's CIF, the Largest Series A Round for a SaaS Company in MENA - Vimarsana News

Wa'ed Ventures Leads a US $27 Million Series A Round for Rewaa, with Participation from STC's CIF, the Largest Series A Round for a SaaS Company in MENA

Wa'ed Ventures Leads a US $27 Million Series A Round for Rewaa, with Participation from STC's CIF, the Largest Series A Round for a SaaS Company in MENA

5 Dominating Speech AI Startups To Watch In 2023 - Vimarsana News

5 Dominating Speech AI Startups To Watch In 2023

Artificial intelligence (AI) companies now strive to innovate technologies that can interpret human language.

Takeaways From KTR Speech at TIE Global Summit 2022 Hyderabad - Vimarsana News

Takeaways From KTR Speech at TIE Global Summit 2022 Hyderabad

Given the volatile, uncertain, complex and ambiguous (VUCA) world we live in, innovation is a critical means by which countries can create and sustain competitive advantage and drive inclusive growth. Entrepreneurs create economic value and need to be motivated, cultivated and nurtured to the greatest degree. Webster’ Dictionary defines “ecosystem” as the complex of a

Source: sakshi.com
Weekly Startup Funding Roundup (November 07 to 11) - Vimarsana News

Weekly Startup Funding Roundup (November 07 to 11)

During second week of October Indian Startup ecosystem received a total venture capital funding of 216 million dollars from 22 funding deals

Quell Therapeutics Expands Series A Financing to $84 Million - Vimarsana News

Quell Therapeutics Expands Series A Financing to $84 Million

Quell Therapeutics Expands Series A Financing to $84 Million Search jobs Quell Therapeutics Expands Series A Financing to $84 Million – Largest Series A in the Treg field –       London, UK – February 11 2021 – Quell Therapeutics Ltd (“Quell”), a biotechnology company developing engineered T regulatory (Treg) cell therapies, today announced the closing of an extended Series A financing led by their existing investors Syncona Ltd (“Syncona”), who have committed an additional $34.7 million and UCL Technology Fund (“UCLTF”) who have committed an additional $1 million; br...